Ibio Inc Stock Analysis

IBIO Stock  USD 2.64  0.19  7.76%   
Ibio Inc is overvalued with Real Value of 1.56 and Target Price of 1.0. The main objective of Ibio stock analysis is to determine its intrinsic value, which is an estimate of what Ibio Inc is worth, separate from its market price. There are two main types of Ibio's stock analysis: fundamental analysis and technical analysis.
The Ibio stock is traded in the USA on NYSE MKT Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Ibio is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. Ibio Stock trading window is adjusted to America/New York timezone.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ibio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Ibio Stock Analysis Notes

About 32.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.36. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ibio Inc recorded a loss per share of 4.03. The entity last dividend was issued on the 11th of June 2018. The firm had 1:20 split on the 29th of November 2023. iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company was incorporated in 2008 and is headquartered in Bryan, Texas. Ibio operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 105 people. To learn more about Ibio Inc call Robert Kay at (979) 446-0027 or check out https://ibioinc.com.

Ibio Inc Investment Alerts

Ibio Inc is way too risky over 90 days horizon
Ibio Inc appears to be risky and price may revert if volatility continues
Ibio Inc has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 225 K. Net Loss for the year was (24.91 M) with profit before overhead, payroll, taxes, and interest of 2.17 M.
Ibio Inc currently holds about 33.52 M in cash with (18.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Ibio Inc has a frail financial position based on the latest SEC disclosures
Latest headline from MacroaxisInsider: Disposition of tradable shares by Banjak Marc of Ibio subject to Rule 16b-3

Ibio Inc Upcoming and Recent Events

Earnings reports are used by Ibio to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
13th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Ibio Largest EPS Surprises

Earnings surprises can significantly impact Ibio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-09-27
2021-06-30-0.040.010.05125 
2023-05-15
2023-03-31-0.36-0.5532-0.193253 
2022-02-14
2021-12-31-1-1.25-0.2525 
View All Earnings Estimates

Ibio Environmental, Social, and Governance (ESG) Scores

Ibio's ESG score is a quantitative measure that evaluates Ibio's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Ibio's operations that may have significant financial implications and affect Ibio's stock price as well as guide investors towards more socially responsible investments.

Ibio Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.3 M.

Ibio Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(1.07)(1.12)
Return On Capital Employed(0.67)(0.70)
Return On Assets(0.87)(0.91)
Return On Equity(1.17)(1.23)

Management Efficiency

Ibio Inc has return on total asset (ROA) of (0.2973) % which means that it has lost $0.2973 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8415) %, meaning that it created substantial loss on money invested by shareholders. Ibio's management efficiency ratios could be used to measure how well Ibio manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of November 2024, Return On Tangible Assets is likely to drop to -1.12. In addition to that, Return On Capital Employed is likely to drop to -0.7. At this time, Ibio's Total Assets are very stable compared to the past year. As of the 23rd of November 2024, Non Current Assets Total is likely to grow to about 17.9 M, while Other Current Assets are likely to drop about 711.5 K.
Last ReportedProjected for Next Year
Book Value Per Share 5.57  5.29 
Tangible Book Value Per Share 4.16  3.96 
Enterprise Value Over EBITDA 0.15  0.15 
Price Book Value Ratio 0.36  0.34 
Enterprise Value Multiple 0.15  0.15 
Price Fair Value 0.36  0.34 
Enterprise Value-1.8 M-1.9 M
The operational strategies employed by Ibio management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Operating Margin
(19.48)
Beta
(3.37)
Return On Assets
(0.30)
Return On Equity
(0.84)

Technical Drivers

As of the 23rd of November, Ibio retains the Risk Adjusted Performance of 0.0893, downside deviation of 4.04, and Market Risk Adjusted Performance of 0.8953. Ibio technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Ibio Inc Price Movement Analysis

The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Ibio middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Ibio Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Ibio Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ibio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ibio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ibio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Ibio Outstanding Bonds

Ibio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ibio Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ibio bonds can be classified according to their maturity, which is the date when Ibio Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Ibio Predictive Daily Indicators

Ibio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ibio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Ibio Corporate Filings

13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
8K
12th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
23rd of October 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
10th of October 2024
Other Reports
ViewVerify
10K
24th of September 2024
An amendment to a previously filed Form 10-K
ViewVerify
8K
20th of September 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F3
14th of August 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
6th of August 2024
Other Reports
ViewVerify

Ibio Forecast Models

Ibio's time-series forecasting models are one of many Ibio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ibio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Ibio Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ibio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ibio shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Ibio. By using and applying Ibio Stock analysis, traders can create a robust methodology for identifying Ibio entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(78.93)(74.98)
Operating Profit Margin(85.02)(80.77)
Net Loss(127.30)(120.94)
Gross Profit Margin(5.24)(4.98)

Current Ibio Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ibio analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ibio analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
1.0Strong Buy2Odds
Ibio Inc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Ibio analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Ibio stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Ibio Inc, talking to its executives and customers, or listening to Ibio conference calls.
Ibio Analyst Advice Details

Ibio Stock Analysis Indicators

Ibio Inc stock analysis indicators help investors evaluate how Ibio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Ibio shares will generate the highest return on investment. By understating and applying Ibio stock analysis, traders can identify Ibio position entry and exit signals to maximize returns.
Begin Period Cash Flow7.6 M
Long Term Debt766 K
Common Stock Shares Outstanding3.8 M
Total Stockholder Equity21.3 M
Property Plant And Equipment Net6.4 M
Cash And Short Term Investments14.2 M
Cash14.2 M
Accounts Payable358 K
Net Debt-9.8 M
50 Day M A2.372
Total Current Liabilities3.8 M
Other Operating Expenses16.9 M
Non Current Assets Total13.1 M
Non Currrent Assets Other1.3 M
Stock Based CompensationM
When determining whether Ibio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ibio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ibio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ibio Inc Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ibio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ibio. If investors know Ibio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ibio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.03)
Revenue Per Share
0.059
Quarterly Revenue Growth
(0.88)
Return On Assets
(0.30)
Return On Equity
(0.84)
The market value of Ibio Inc is measured differently than its book value, which is the value of Ibio that is recorded on the company's balance sheet. Investors also form their own opinion of Ibio's value that differs from its market value or its book value, called intrinsic value, which is Ibio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ibio's market value can be influenced by many factors that don't directly affect Ibio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ibio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ibio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ibio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.